Recombinant Proteins Market To Reach USD 3,203.7 Million by 2030, Says P&S Intelligence

NEW YORK, March 2, 2023 /PRNewswire/ -- The global recombinant proteins market was worth USD 1,367.3 million in 2022, and it will grow at a rate of 11.2%, to reach USD 3,203.7 million by 2030, as claimed by P&S Intelligence in one of its reports.

Increasing Usage of Recombinant Protein Drugs for Rare Disorders

• The increasing incidence of numerous rare disorders, including multiple sclerosis, cerebral apoplexy, neutropenia, anemia, and dwarfism, is pushing up the requirement for drugs made from recombinant proteins.
• Moreover, these biologics are utilized for the enhancement of new-age therapies for severe chronic ailments, such as cancer, CVDs, endocrinal ailments, and viral sicknesses.

Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/recombinant-proteins-market/report-sample

Biologic Discovery & Development Is a Major Use of Recombinant Proteins

Biologics dominate the industry, under the drug discovery and development sub-segment, with a share of about 60%, and they will grow the fastest in the future.

This is because of the rising focus of biopharma and pharma companies on growing their biologics and biosimilars research & development portfolios, producing new technologies, and further enhancing the bioprocessing science.

This is itself an outcome of the increasing requirement for biopharmaceuticals, their wide applications, and the rising competition amongst the key players.

Pharma Firms in APAC Rapidly Upping Their Purchase of Recombinant Proteins

North America had the largest share, of 45%, because of the increasing incidence of chronic and infectious ailments and favorable initiatives of the government.

Moreover, the growing requirement for these products in the R&D studies being executed by the main players is boosting the regional industry.

APAC will grow the fastest in the years to come, ascribed to the extensive growth in pharma CDMO efforts in the recent past.

Furthermore, the increasing population, its growing demand for an enhanced access to drugs, and the increasing affordability of biopharmaceuticals, with the launch of generics, are responsible for the growth of the industry.

Browse detailed report on Recombinant Proteins Market Size, Share, Growth and Forecast Report 2030

Growth Factors and Chemokines Are Used Most Widely

The growth factors and chemokines category conquered the market, and its growth will be at a rate of about 12% in the future. This can be credited to the use of chemokines and growth factors in numerous research studies for cancer, COVID-19, neurobiology, and HIV/AIDS and immunology.

Moreover, the usage of cytokines and growth factors for research could unlock the secrets of molecular biology. For example, there is a prodigious potential for developing insulin with the use of KP1 and quickening the wound healing procedure in diabetic patients, who account for a substantial chunk of the population worldwide.

Recombinant Protein Market Segmentation Coverage

Recombinant Protein Market by End User

• Pharmaceutical & Biopharmaceutical Companies
• Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations

Recombinant Protein Market by Application

• Drug Discovery & Development
• Biopharmaceutical Production
• Biotechnology Research
• Academic Research Studies
• Diagnostics

Recombinant Protein Market by Product

• Growth Factors and Chemokines
• Immune Response Proteins
• Structural Proteins
• Membrane Proteins
• Kinase Proteins
• Regulatory Proteins
• Recombinant Metabolic Enzymes
• Adhesion Molecules and Receptors

Recombinant Protein Market Regional Analysis

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia-Pacific
• Japan
• China
• India
• South Korea
• Australia
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• Saudi Arabia
• South Africa
• U.A.E.

Browse More Reports Published by P&S

Medical Gases and Equipment Market Share, Development and Demand Forecast to 2030

Advanced Visualization Market Growth, Development and Demand Forecast to 2030

eClinical Solutions Market Growth, Development and Demand Forecast to 2030

Portable Ultrasound Devices Market Growth, Development and Demand Forecast to 2030

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg

SOURCE P&S Intelligence